Bishop Hans Edgar

CEO & President at Juno Therapeutics, Inc.

Sold, on record
$30.1M
Dollars the filings state
Form 4 sales
8
Latest Jan 16, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Dec 15, 2015 2015

    Sold 91,500 shares at $45.72 ($4.2M)

    Bishop Hans Edgar, CEO and President

    Sold 3.3% of holdings ($127M position)2.7M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Feb 29, 2016 +76 days

    Sold 90,750 shares at $35.32 ($3.2M)

    Bishop Hans Edgar, Officer, Director

    Sold 3.3% of holdings ($96.8M position)2.7M shares leftFiling

  3. 3 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Jun 9, 2016 +101 days

    Sold 90,750 shares at $46.42 ($4.2M)

    Bishop Hans Edgar, CEO & President

    Sold 3.4% of holdings ($126M position)2.6M shares leftFiling

  4. 4 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Aug 31, 2016 +83 days

    Sold 42,673 shares at $30.06 ($1.3M)

    Bishop Hans Edgar, CEO & President

    Sold 1.7% of holdings ($77M position)2.5M shares left0.5x usual sizeFiling

  5. 5 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Sep 8, 2016 +8 days

    Sold 23,042 shares at $30.06 ($693k)

    Bishop Hans Edgar, CEO & President

    Sold 0.9% of holdings ($76.4M position)2.5M shares left0.3x usual sizeFiling

  6. 6 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Sep 21, 2016 +13 days

    Sold 84,035 shares at $30.28 ($2.5M)

    Bishop Hans Edgar, CEO & President

    Sold 3.3% of holdings ($76.6M position)2.4M shares left0.9x usual sizeFiling

  7. 7 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Sep 27, 2016 +6 days

    Sold 44,000 shares at $33.00 ($1.5M)

    Bishop Hans Edgar, CEO & President

    Sold 1.8% of holdings ($82.2M position)2.4M shares left0.5x usual sizeFiling

  8. 8 Form 4 sale Juno Therapeutics, Inc.Unusual
    Jan 16, 2018 +476 days

    Sold 270,250 shares at $46.17 ($12.5M)

    Bishop Hans Edgar, CEO & President

    Sold 9.7% of holdings ($128M position)2.5M shares left4.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Bishop Hans Edgar
Source
Jan 16, 2018Jan 18, 2018Juno Therapeutics, Inc.CEO & PresidentForm 4 sale270,250$12.5M9.7%UnusualSEC
Sep 27, 2016Sep 29, 2016Juno Therapeutics, Inc.CEO & PresidentForm 4 sale44,000$1.5M1.8%Plan not statedSEC
Sep 21, 2016Sep 21, 2016Juno Therapeutics, Inc.CEO & PresidentForm 4 sale84,035$2.5M3.3%Plan not statedSEC
Sep 8, 2016Sep 9, 2016Juno Therapeutics, Inc.CEO & PresidentForm 4 sale23,042$693k0.9%Plan not statedSEC
Aug 31, 2016Sep 2, 2016Juno Therapeutics, Inc.CEO & PresidentForm 4 sale42,673$1.3M1.7%Plan not statedSEC
Jun 9, 2016Jun 13, 2016Juno Therapeutics, Inc.CEO & PresidentForm 4 sale90,750$4.2M3.4%Plan not statedSEC
Feb 29, 2016Mar 2, 2016Juno Therapeutics, Inc.Officer, DirectorForm 4 sale90,750$3.2M3.3%Plan not statedSEC
Dec 15, 2015Dec 17, 2015Juno Therapeutics, Inc.CEO and PresidentForm 4 sale91,500$4.2M3.3%Plan not statedSEC